SARS-CoV-2 Infection Leads to Neurological Dysfunction

被引:68
作者
Acharya, Arpan [1 ]
Kevadiya, Bhavesh D. [1 ,2 ]
Gendelman, Howard E. [1 ]
Byrareddy, Siddappa N. [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA
[2] Stanford Univ, Dept Radiol, Intervent Regenerat Med & Imaging Lab, Palo Alto, CA 94304 USA
关键词
COVID-19; SARS-CoV-2; CNS; Neurologic manifestations; Animal models; Guillain-Barre syndrome; Therapeutics; CORONAVIRUS SPIKE PROTEIN; CENTRAL-NERVOUS-SYSTEM; ZIKA; IDENTIFICATION; REPLICATION; ABSENCE;
D O I
10.1007/s11481-020-09924-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A number of neurological disease complications have been seen following infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While most person with COVID-19 respiratory disease demonstrate headache, nausea and vomiting, up to 40% present also experience dizziness, confusion, cerebrovascular disease, muscle pain, ataxia and seizures. Loss of taste and smell, defects in visual acuity and pain occur in parallel. Such central nervous system (CNS) signs and symptoms linked to laboratory-confirmed SARS-CoV-2 infection is often life threatening. Health care providers currently evaluating patients with neurologic symptoms need consider COVID-19 in any differential diagnosis. These considerations will facilitate prompt testing, isolation and prevention of viral transmission speeding best clinical outcomes.
引用
收藏
页码:167 / 173
页数:7
相关论文
共 60 条
[1]   DEDUCED SEQUENCE OF THE BOVINE CORONAVIRUS SPIKE PROTEIN AND IDENTIFICATION OF THE INTERNAL PROTEOLYTIC CLEAVAGE SITE [J].
ABRAHAM, S ;
KIENZLE, TE ;
LAPPS, W ;
BRIAN, DA .
VIROLOGY, 1990, 176 (01) :296-301
[2]   The proximal origin of SARS-CoV-2 [J].
Andersen, Kristian G. ;
Rambaut, Andrew ;
Lipkin, W. Ian ;
Holmes, Edward C. ;
Garry, Robert F. .
NATURE MEDICINE, 2020, 26 (04) :450-452
[3]  
Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253
[4]   Neuroinvasion by human respiratory coronaviruses [J].
Arbour, N ;
Day, R ;
Newcombe, J ;
Talbot, PJ .
JOURNAL OF VIROLOGY, 2000, 74 (19) :8913-8921
[5]   Guillain-Barree syndrome in patients with a recent history of Zika in Cucuta, Colombia: A descriptive case series of 19 patients from December 2015 to March 2016 [J].
Arias, Arturo ;
Torres-Tobar, Lilian ;
Hernandez, Gualberto ;
Paipilla, Deyanira ;
Palacios, Eduardo ;
Torres, Yahaira ;
Duran, Julian ;
Sebastian Ugarte, U. ;
Ardila-Sierra, Adriana ;
Castellanos, Gabriel .
JOURNAL OF CRITICAL CARE, 2017, 37 :19-23
[6]   Central nervous system manifestations of COVID-19: A systematic review [J].
Asadi-Pooya, Ali A. ;
Simani, Leila .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 413
[7]   Global aspects of viral glycosylation [J].
Bagdonaite, Ieva ;
Wandall, Hans H. .
GLYCOBIOLOGY, 2018, 28 (07) :443-467
[8]   Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms [J].
Baig, Abdul Mannan ;
Khaleeq, Areeba ;
Ali, Usman ;
Syeda, Hira .
ACS CHEMICAL NEUROSCIENCE, 2020, 11 (07) :995-998
[9]   Prevalence of Guillain-Barre syndrome among Zika virus infected cases: a systematic review and meta-analysis [J].
Barbi, Ludovica ;
Campos Coelho, Antonio Victor ;
Arraes de Alencar, Luiz Claudio ;
Crovella, Sergio .
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2018, 22 (02) :137-141
[10]   Architecture of the SARS coronavirus prefusion spike [J].
Beniac, Daniel R. ;
Andonov, Anton ;
Grudeski, Elsie ;
Booth, Tim F. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2006, 13 (08) :751-752